Clinical Chemistry and Laboratory Medicine

Aims & Scope

Clinical Chemistry and Laboratory Medicine (CCLM) publishes articles on novel teaching and training methods applicable to laboratory medicine.

CCLM welcomes contributions on the progress in fundamental and applied research and cutting-edge clinical laboratory medicine.

It is one of the leading journals in the field, with an impact factor over 3.

CCLM is issued monthly, and it is published in print and electronically.

Letters to the Editor and Congress Abstracts are published only electronically.

Topics clinical biochemistry clinical genomics and molecular biology clinical haematology and coagulation clinical immunology and autoimmunity clinical microbiology drug monitoring and analysis evaluation of diagnostic biomarkers disease-oriented topics (cardiovascular disease, cancer diagnostics, diabetes) new reagents, instrumentation and technologies new methodologies reference materials and methods reference values and decision limits quality and safety in laboratory medicine translational laboratory medicine clinical metrology.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.7
2024	3.80

SJR (SCImago Journal Rank)

Year	Value
2024	0.952

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	127

Journal Rank

Year	Value
2024	5242

Journal Citation Indicator

Year	Value
2024	2796

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis

  Citation: 1430

  Authors: Brandon Michael, Maria Helena Santos, Stefanie, Mario, Giuseppe

• Prominent changes in blood coagulation of patients with SARS-CoV-2 infection

  Citation: 901

  Authors: Huan, Lan, Rui, Fang, Kai-lang, Jie, Xing-hui, Cheng-liang

• Laboratory abnormalities in patients with COVID-2019 infection

  Citation: 660

  Authors: Giuseppe, Mario

• Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa

  Citation: 628

  Authors: Jens, Christian, Ulf, Tobias, Raija, Ã…sa, Victor, Niklas, Kaj, Henrik

• Biochemical markers of muscular damage

  Citation: 582

  Authors: Paola, Giuseppe, Nicola

• Approved IFCC Reference Method for the Measurement of HbA1c in Human Blood

  Citation: 467

  Authors: Jan-Olof, Uwe, John, Andreas, Wieland, Tadao, Kor, Andrea, Pierluigi, Rita, Linda, Masao, Cas

• Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)

  Citation: 452

  Authors: Giuseppe, Ana-Maria, Mario

• Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine

  Citation: 415

  Authors: Sverre, Callum G., Andrea Rita, Rob, Graham, Wytze, Per Hyltoft, Heinz, Ken, Mauro

• Errors in clinical laboratories or errors in laboratory medicine?

  Citation: 392

  Authors: Mario

• First certified reference material for cystatin C in human serum ERM-DA471/IFCC

  Citation: 335

  Authors: Anders, Søren, Veronica, Camilla, Harald, Ingrid

---